Publications (10)

2023

  1. Role of previous systemic antibiotic therapy on the probability of recurrence after an initial episode of Clostridioides difficile infection treated with vancomycin

    JAC-Antimicrobial Resistance, Vol. 5, Núm. 2

2022

  1. High Incidence of Asymptomatic Phase I IgG Seroconversion After an Acute Q Fever Episode: Implications for Chronic Q Fever Diagnosis

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 74, Núm. 12, pp. 2122-2128

  2. Impact of COVID19 pandemic on the incidence of health-care associated Clostridioides difficile infection

    Anaerobe, Vol. 75

2016

  1. Common haplotypes in CD209 promoter and susceptibility to HIV-1 infection in intravenous drug users

    Infection, Genetics and Evolution, Vol. 45, pp. 20-25

2015

  1. Association of complement receptor 2 polymorphisms with innate resistance to HIV-1 infection

    Genes and Immunity, Vol. 16, Núm. 2, pp. 134-141

  2. IFNL4 rs368234815 polymorphism is associated with innate resistance to HIV-1 infection

    AIDS

2014

  1. Association of low-density lipoprotein receptor genotypes with hepatitis C viral load

    Genes and Immunity, Vol. 15, Núm. 1, pp. 16-24

  2. IFNL4 ss469415590 variant shows similar performance to rs12979860 as predictor of response to treatment against hepatitis C virus genotype 1 or 4 in Caucasians

    PLoS ONE, Vol. 9, Núm. 4

2013

  1. A model to predict the response to therapy against hepatitis C virus (HCV) including low-density lipoprotein receptor genotype in HIV/HCV-coinfected patients

    Journal of Antimicrobial Chemotherapy, Vol. 68, Núm. 4, pp. 915-921

  2. Variations at multiple genes improve interleukin 28B genotype predictive capacity for response to therapy against hepatitis C infection

    AIDS, Vol. 27, Núm. 17, pp. 2715-2724